ClinicalTrials.Veeva

Menu

Diacutaneous Fibrolysis and Patellofemoral Pain Syndrome

U

University of Zaragoza

Status and phase

Completed
Phase 3

Conditions

Patellofemoral Pain Syndrome

Treatments

Device: Diacutaneous Fibrolysis

Study type

Interventional

Funder types

Other

Identifiers

Details and patient eligibility

About

The aim of the study will be to assess the effectiveness of Diacutaneous Fibrolysis technique on pain, range of motion (Patellofemoral joint mobility test and muscle length test), strength and function in patients with Patellofemoral Pain Syndrome and muscle shortening.

Muscle imbalance is one of most important factor associated with Patellofemoral Pain Syndrome. Shortening of lateral muscles of the thigh have a close relationship with patella position and tracking and patellofemoral pain. The scientific evidence for effectiveness of any soft tissue mobilization technique in patellofemoral pain syndrome patients is poor.

Diacutaneous Fibrolysis is a non-invasive physiotherapeutic technique to release adherences and fibrosis between the different musculoskeletal structures. Diacutaneous Fibrolysis is applied by a set of metallic hooks having the advantage of allowing a deeper and more precise application, which could not be achieved manually.

The present study evaluates the effectiveness of Diacutaneous Fibrolysis technique applied in the soft tissues more related with patellofemoral pain.

Enrollment

60 patients

Sex

All

Ages

16 to 40 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Unilateral or bilateral patellofemoral pain longer than three months
  • Anterior or retropatellar pain of non-traumatic origin that is provoked by at least two of the following activities: prolonged sitting or kneeling, squatting, running, hopping, jumping, or stair ascending/descending.
  • The presence of pain on palpation of the patellar facets, on step down from 25 cm step, or during a double leg squat.
  • Pain over the previous week equal to or greater than 3 on a 10-cm visual analogue scale.
  • The presence of muscle shortening in rectus femoris or tensor fascia lata muscle length test and/or hypo-mobility or stiffness in the compartmental muscle play.

Exclusion criteria

  • Previous knee surgery or traumatic lesions
  • Concomitant injury or pathology of other knee structures
  • History of patella subluxation or dislocation
  • Evidence of knee joint effusion
  • Pain in and/or referred from the hip or lumbar spine
  • Currently undergoing physiotherapy treatment for Patellofemoral pain syndrome or use anti-inflammatories or corticosteroid medication at the same time of the study.
  • Subjects unable or unwilling to give informed to written consent or fulfil questionnaires.

Trial design

Primary purpose

Treatment

Allocation

N/A

Interventional model

Single Group Assignment

Masking

None (Open label)

60 participants in 1 patient group

Intervention group
Experimental group
Description:
Diacutaneous Fibrolysis treatment
Treatment:
Device: Diacutaneous Fibrolysis

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems